| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2009/10/14 | 05:05 | Business Wire | Allos Therapeutics Announces Closing of Public Offering | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/13 | 19:40 | Marketwired | ELNK, HERO, ABAT, NTAP, DBRN and ALTH Receives Analytical Coverage from WallStSense.com | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/08 | 06:08 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/07 | 19:19 | Edgar (US Regulatory) | Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/07 | 19:14 | Business Wire | Allos Therapeutics Announces Pricing of Public Offering of Common Stock | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/06 | 05:08 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/06 | 05:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/06 | 05:01 | Business Wire | Allos Therapeutics Announces Proposed Public Offering of Common Stock | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/05 | 21:12 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/05 | 20:00 | Business Wire | Allos Therapeutics Announces U.S. Availability of FOLOTYN™ (pralatrexate injection) for Relapsed or Refractory Peripheral T... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/03 | 06:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/10/01 | 19:36 | Marketwired | RothmanResearch.com Stock Review for SCG, CA, NE, MKC, COL and ALTH | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/09/25 | 21:45 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/09/25 | 20:00 | Business Wire | Allos Therapeutics’ FOLOTYN™ First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/09/12 | 05:15 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/09/03 | 21:52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/09/03 | 07:09 | Business Wire | Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN™ (pralatrexate) for the Trea... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/09/02 | 19:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/09/01 | 22:05 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/09/01 | 21:00 | Business Wire | Allos Therapeutics to Hold Post Advisory Committee Conference Call | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/31 | 22:31 | PR Newswire (US) | Seven Summits Research Releases Comments on Boeing, Joy Global, Ciena Corporation, TakeTwo Interactive and Allos Therapeutics | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/29 | 02:27 | Dow Jones News | FDA Has Several Issues With Allos Data For Folotyn | NASDAQ:ALTH | Allos Therapeutics Inc. |
| 2009/08/15 | 05:16 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/13 | 07:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/13 | 06:59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/11 | 05:04 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/10 | 23:25 | Business Wire | Allos Therapeutics Announces FDA Advisory Committee to Review Pralatrexate for the Treatment of Patients with Relapsed or Ref... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/08 | 07:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/06 | 07:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2009/08/06 | 07:01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |